Regulation & Compliance

Klothea Bio's trial for a 'longevity protein' drug in Honduras pushes the boundaries of science, but raises questions about offshore research and equity.

Arqit and 6WIND have teamed up to offer quantum-safe VPNs, arming telcos against the looming threat of 'harvest now, decrypt later' data breaches.

A new partnership brings AI-powered video assessment to clinical education, aiming to better prepare students for real-world healthcare challenges.

A new partnership brings continuous health monitoring to premium care, signaling a major shift toward data-driven, value-based personalized medicine.

As B Corp certification gets stricter, a Raleigh-based sustainability platform is launching a new service to help businesses navigate the rigorous requirements.

Rich Friedberg's appointment as CISO signals a strategic shift, leveraging AI and deep security integration to protect a massive wealth management ecosystem.

As AI assistants accelerate code generation, Moderne's new tooling offers enterprises a way to automate large-scale Python fixes and control code sprawl.

A new study reveals Apache Iceberg is core to enterprise AI, but its rapid adoption has created a critical 'operational gap' that companies are now rushing to fill.

A new program helps personal injury lawyers offer holistic support, guiding clients through the complex world of disability rights after an accident.

The Swedish tech firm will debut its AI Checklist Builder and Safety Alerts at CONEXPO 2026, aiming to transform high-risk industrial operations.

The virtual care provider extends its specialized behavioral health services for Medicare patients to Arizona, Illinois, and Indiana amid a provider shortage.

Innoviva prepares for a key investor conference, spotlighting its shift to specialty drugs and navigating questions on its diversified growth strategy.

Clene Inc. faces investors with promising data for ALS and MS, but a looming cash crunch makes its upcoming conference a critical test of survival.

An international team receives a major grant to use artificial intelligence to predict survival and treatment response, offering new hope for a deadly disease.

FinTech leader Derivative Path promotes Zack Nagelberg to President, signaling a strategic push into AI-driven risk management for evolving capital markets.

The cannabis giant's landmark debt deal signals new institutional confidence, but a high interest rate reveals the industry's costly reality.

Reunion Neuroscience hits the investor conference circuit, seeking capital to advance its groundbreaking psychedelic-inspired therapies for depression and anxiety.

Fractal's new healthcare AI has surpassed leading models from OpenAI and Google, signaling a major leap for India's sovereign AI ambitions and public health.

The mobile health firm now reaches 25 states with its tech-driven model, aiming to close care gaps and answer federal critics of in-home assessments.

A new partnership between WELL Health and HEALWELL AI uses artificial intelligence to find trial participants, but puts patient consent at the forefront.